title: Safer, more expensive iodinated contrast agents: how do we decide?
abstract: The advantages of the new, safer, but more expensive iodinated contrast agents are discussed, and opinions on which patient groups should receive the agents are presented.
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000009:adverse effects*; D003365:Costs and Cost Analysis; D006801:Humans; D007472:Iohexol; D007479:Iopamidol; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D008793:Metrizamide / Q000009:adverse effects; D008875:Middle Aged; D011859:Radiography / Q000191:economics; D012306:Risk; D014283:Triiodobenzoic Acids / Q000009:adverse effects
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; D007483:Iothalamic Acid; D007472:Iohexol; D007479:Iopamidol; D008793:Metrizamide